A high-quality genome assembly of Silene latifolia was generated by researchers at CNRS/Université Claude Bernard Lyon 1 and ...
Fintel on MSN9h
Goldman Sachs Initiates Coverage of Silence Therapeutics plc - Depositary Receipt () (SLN) with Sell RecommendationFintel reports that on February 11, 2025, Goldman Sachs initiated coverage of Silence Therapeutics plc - Depositary Receipt ( ...
The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.
RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...
The table below is a review of notable updates that occurred in January 2025 for investigational products in development.
Scientists have discovered that some tiny segments of RNA thought to be junk instead have a functional role in suppressing ...
Synthetic cells that look just like natural cells but are chemically reversed could outcompete other living organisms − with ...
News Medical on MSN4h
Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cellsVimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and lymphatic tissue (mesenchymal cells). Despite being widely ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback